Human Coagulation Factor VIII (Hemarus Therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman Coagulation Factor VIII (Hemarus Therapeutics)
Drug Alias NameCLOTATE
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2015/08/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHemarus Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHemarus Therapeutics
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksN/A